%0 Journal Article
%T Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease
%A Christopher Assaid
%A David Michelson
%A Heather Leibensperger
%A Jeffrey Cummings
%A Jerry Li
%A Kerry Budd McMahon
%A Linda Snow-Adami
%A Martin Farlow
%A Michael Egan
%A Samar Froman
%J Archive of "Alzheimer's & Dementia : Translational Research & Clinical Interventions".
%D 2018
%R 10.1016/j.trci.2018.03.004
%X We evaluated the selective M1 muscarinic positive allosteric modulator, MK-7622, as adjunctive cognitive enhancing therapy in individuals with Alzheimer's disease
%K MK-7622
%K Alzheimer's disease
%K Cholinergic
%K Muscarinic
%K Allosteric modulator
%K Clinical trial
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021552/